FDA solicits advisory panel nominees
This article was originally published in The Tan Sheet
Executive SummaryFDA schedules a public meeting to provide information on serving on or nominating members to advisory committees April 30 at the agency's Center for Drug Evaluation and Research in Rockville, Md. In a March 30 Federal Register 1notice, FDA says the meeting will inform individuals and groups with consumer interests about the nomination and selection process. The Nonprescription Drugs Advisory Committee currently has three vacancies while the Food Advisory Committee no vacancies, according to FDA's Web site
You may also be interested in...
Phase Ib data at ASH look competitive with new pivotal trial results for Bristol/bluebird’s leading BCMA CAR-T bb2121. The Phase II portion of the CARTITUDE-1 study for JNJ-4528 is fully enrolled.
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.